Hudson Bay Capital Management
OACC

Hudson Bay Capital Management’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Hudson Bay Capital Management’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.19M Sell
300,000
-100,000
-25% -$1.06M 0.01% 640
2025
Q4 		$4.25M Hold
400,000
– – 0.01% 545
2025
Q3 		$4.19M Hold
400,000
– – 0.01% 597
2025
Q2 		$4.19M Sell
400,000
-50,000
-11% -$519K 0.01% 589
2025
Q1 		$4.59M Buy
+450,000
New +$4.52M 0.01% 614

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Hudson Bay Capital Management's OACC Position: Q1 2026 in Review

Hudson Bay Capital Management reduced its Oaktree Acquisition Corp III Life Sciences (OACC) stake by 25% in Q1 2026, selling an estimated $1.06M and leaving 300,000 shares worth $3.19M. The position accounts for 0.01% of the portfolio, ranked #640.

Hudson Bay Capital Management first reported a position in OACC in Q1 2025 and has held it in 5 quarters since. The position peaked at $4.59M in Q1 2025. 51 funds tracked by Wall St. Rank hold OACC as of Q1 2026.

  • Hudson Bay Capital Management held 300,000 shares of Oaktree Acquisition Corp III Life Sciences worth $3.19M as of Q1 2026.
  • Hudson Bay Capital Management sold 100,000 Oaktree Acquisition Corp III Life Sciences shares in Q1 2026, an estimated $1.06M.
  • Oaktree Acquisition Corp III Life Sciences made up 0.01% of Hudson Bay Capital Management's portfolio in Q1 2026, its #640 holding.
  • Hudson Bay Capital Management first reported a position in Oaktree Acquisition Corp III Life Sciences in Q1 2025 and has held it in 5 quarters since.
  • Hudson Bay Capital Management's Oaktree Acquisition Corp III Life Sciences position peaked at $4.59M in Q1 2025.
  • 51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.